The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease

The features of mucosa-associated microbiota in primary sclerosing cholangitis

(2016) J. Torres et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Cancer Risk and Surveillance in Primary Sclerosing Cholangitis

(2016) Trine Folseraas et al.   Clinics in Liver Disease

Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis

(2016) Long-Xian Lv et al.   ENVIRONMENTAL MICROBIOLOGY

Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis

(2016) Malte Christoph Rühlemann et al.   GUT

Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD

(2016) João Sabino et al.   GUT

The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls

(2016) Martin Kummen et al.   GUT

Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology

(2016) Yanfei Chen et al.   Scientific Reports

Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?

(2015) P. Pavlidis et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease

(2015) J. E. Eaton et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials

(2015) L Vuitton et al.   GUT

Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis

(2015) James H. Tabibian et al.   HEPATOLOGY

Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis

(2015) D. Kevans et al.   Journal of Crohns & Colitis

The Interplay of the Gut Microbiome, Bile Acids, and Volatile Organic Compounds

(2015) Nidhi M. Sagar et al.   Gastroenterology Research and Practice

Bile acids and the gut microbiome

(2014) Jason M. Ridlon et al.   CURRENT OPINION IN GASTROENTEROLOGY

The bile acid TGR5 membrane receptor: From basic research to clinical application

(2014) Henri Duboc et al.   DIGESTIVE AND LIVER DISEASE

The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention

(2014) Mitchell L Jones et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Reprograming of gut microbiome energy metabolism by the FUT2 Crohn’s disease risk polymorphism

(2014) Maomeng Tong et al.   ISME Journal

The Mucosa-associated Microbiota of PSC Patients is Characterized by Low Diversity and Low Abundance of Uncultured Clostridiales II

(2014) Noortje G. Rossen et al.   Journal of Crohns & Colitis

Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies

(2014) James H. Tabibian et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach

(2013) Xiao Wei et al.   BMC GASTROENTEROLOGY

Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management

(2013) John E. Eaton et al.   GASTROENTEROLOGY

Modulation of the fecal bile acid profile by gut microbiota in cirrhosis

(2013) Genta Kakiyama et al.   JOURNAL OF HEPATOLOGY

Altered profile of human gut microbiome is associated with cirrhosis and its complications

(2013) Jasmohan S. Bajaj et al.   JOURNAL OF HEPATOLOGY

Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis

(2013) James H. Tabibian et al.   Biomed Research International

PANDAseq: paired-end assembler for illumina sequences

(2012) Andre P Masella et al.   BMC BIOINFORMATICS

Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases

(2012) Henri Duboc et al.   GUT

Serial Analysis of the Gut and Respiratory Microbiome in Cystic Fibrosis in Infancy: Interaction between Intestinal and Respiratory Tracts and Impact of Nutritional Exposures

(2012) J. C. Madan et al.   mBio

Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease

(2011) J. Torres et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Carcinogenicity of deoxycholate, a secondary bile acid

(2011) Carol Bernstein et al.   ARCHIVES OF TOXICOLOGY

Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats

(2011) K.B.M. Saiful Islam et al.   GASTROENTEROLOGY

Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance

(2011) Robert Goldstone et al.   INFLAMMATORY BOWEL DISEASES

Oral Microbiome Profiles: 16S rRNA Pyrosequencing and Microarray Assay Comparison

(2011) Jiyoung Ahn et al.   PLoS One

Metagenomic biomarker discovery and explanation

(2011) Nicola Segata et al.   GENOME BIOLOGY

Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity

(2010) Severine Vermeire et al.   Clinical Gastroenterology and Hepatology

QIIME allows analysis of high-throughput community sequencing data

(2010) J Gregory Caporaso et al.   NATURE METHODS

Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis

(2008) James D. Lewis et al.   INFLAMMATORY BOWEL DISEASES

Intestinal bile acid physiology and pathophysiology

(2008) Olga Martínez-Augustin et al.   WORLD JOURNAL OF GASTROENTEROLOGY